About
Thomas Edlund is a Swedish molecular genetics professor and biotech scientific founder associated with Umea University and Amplifier Therapeutics. Amplifier describes him as Scientific Founder and Chief Scientific Officer, and notes that he co-founded Symbicom AB and Uman Genomics AB and served on the scientific advisory board of Ontogeny Inc. Public biotech press also identifies him as CEO of Balticgruppen Bio AB/Betagenon, where he was involved in fundraising for AMPK-activator drug development.
Areas of interest
biotechlongevityaging-related diseasescardiometabolic diseaseAMPK activatorsmolecular geneticspancreas biologyinsulin gene expressiondrug development